Categories: HealthcareNews

SS&C to Participate at Upcoming Investor Conferences

WINDSOR, Conn., Dec. 2, 2024 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of software and software-enabled services for the financial services and healthcare industries, today announced Bill Stone, Chairman and Chief Executive Officer, will present at the UBS Global Technology and AI Conference at The Phoenician in Scottsdale, Arizona, on Thursday, December 5th, 2024 at 12:15 PM MT.

SS&C also announced Brian Schell, Chief Financial Officer, will present at The Nasdaq 51st Investor Conference, held in association with Morgan Stanley, at The May Fair Hotel in London, United Kingdom, on Tuesday, December 10th at 3:00 PM GMT.

Webcast will be available on SS&C Technologies’ investor relations website at http://investor.ssctech.com .

About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 20,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.

Additional information about SS&C (Nasdaq:SSNC) is available at www.ssctech.com.

Follow SS&C on Twitter, Linkedin and Facebook.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ssc-to-participate-at-upcoming-investor-conferences-302319139.html

SOURCE SS&C

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

2 hours ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

2 hours ago